Research Portal

EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle

Research output: Contribution to journal › Article › peer-review

Standard Standard

EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle. / Paredes, Roberto; Schneider, Marion; Pearson, Stella et al.
In: Molecular Biology Reports, Vol. 47, No. 10, 2020, p. 8293-8300.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Paredes, R, Schneider, M, Pearson, S, Teng, HY, Kelly, JR, Pierce, A, Somervaille, TCP, Whetton, AD & Meyer, S 2020, 'EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle', Molecular Biology Reports, vol. 47, no. 10, pp. 8293-8300. https://doi.org/10.1007/s11033-020-05829-1

APA

Paredes, R., Schneider, M., Pearson, S., Teng, H. Y., Kelly, J. R., Pierce, A., Somervaille, T. C. P., Whetton, A. D., & Meyer, S. (2020). EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle. Molecular Biology Reports, 47(10), 8293-8300. https://doi.org/10.1007/s11033-020-05829-1

CBE

Paredes R, Schneider M, Pearson S, Teng HY, Kelly JR, Pierce A, Somervaille TCP, Whetton AD, Meyer S. 2020. EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle. Molecular Biology Reports. 47(10):8293-8300. https://doi.org/10.1007/s11033-020-05829-1

MLA

Paredes, Roberto et al. "EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle". Molecular Biology Reports. 2020, 47(10). 8293-8300. https://doi.org/10.1007/s11033-020-05829-1

VancouverVancouver

Paredes R, Schneider M, Pearson S, Teng HY, Kelly JR, Pierce A et al. EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle. Molecular Biology Reports. 2020;47(10):8293-8300. doi: 10.1007/s11033-020-05829-1

Author

Paredes, Roberto ; Schneider, Marion ; Pearson, Stella et al. / EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle. In: Molecular Biology Reports. 2020 ; Vol. 47, No. 10. pp. 8293-8300.

RIS

TY - JOUR

T1 - EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle

AU - Paredes, Roberto

AU - Schneider, Marion

AU - Pearson, Stella

AU - Teng, Hsiang Yin

AU - Kelly, James R.

AU - Pierce, Andrew

AU - Somervaille, Tim C. P.

AU - Whetton, Anthony D.

AU - Meyer, Stefan

PY - 2020

Y1 - 2020

N2 - Aberrantly high expression of EVI1 in acute myeloid leukaemia (AML) is associated with poor prognosis. For targeted treatment of EVI1 overexpressing AML a more detailed understanding of aspects of spatiotemporal interaction dynamics of the EVI1 protein is important. EVI1 overexpressing SB1690CB AML cells were used for quantification and protein interaction studies of EVI1 and ΔEVI1. Cells were cell cycle-synchronised by mimosine and nocodazole treatment and expression of EVI1 and related proteins assessed by western blot, immunoprecipitation and immunofluorescence. EVI1 protein levels oscillate through the cell cycle, and EVI1 is degraded partly by the proteasome complex. Both EVI1 and ΔEVI1 interact with the co-repressor CtBP1 but dissociate from CtBP1 complexes during mitosis. Furthermore, a large fraction of EVI1, but not ΔEVI1 or CtBP1, resides in the nuclear matrix. In conclusion, EVI1- protein levels and EVI1-CtBP1 interaction dynamics vary though the cell cycle and differ between EVI1 and ΔEVI1. These data ad to the functional characterisation of the EVI1 protein in AML and will be important for the development of targeted therapeutic approaches for EVI1-driven AML.

AB - Aberrantly high expression of EVI1 in acute myeloid leukaemia (AML) is associated with poor prognosis. For targeted treatment of EVI1 overexpressing AML a more detailed understanding of aspects of spatiotemporal interaction dynamics of the EVI1 protein is important. EVI1 overexpressing SB1690CB AML cells were used for quantification and protein interaction studies of EVI1 and ΔEVI1. Cells were cell cycle-synchronised by mimosine and nocodazole treatment and expression of EVI1 and related proteins assessed by western blot, immunoprecipitation and immunofluorescence. EVI1 protein levels oscillate through the cell cycle, and EVI1 is degraded partly by the proteasome complex. Both EVI1 and ΔEVI1 interact with the co-repressor CtBP1 but dissociate from CtBP1 complexes during mitosis. Furthermore, a large fraction of EVI1, but not ΔEVI1 or CtBP1, resides in the nuclear matrix. In conclusion, EVI1- protein levels and EVI1-CtBP1 interaction dynamics vary though the cell cycle and differ between EVI1 and ΔEVI1. These data ad to the functional characterisation of the EVI1 protein in AML and will be important for the development of targeted therapeutic approaches for EVI1-driven AML.

U2 - 10.1007/s11033-020-05829-1

DO - 10.1007/s11033-020-05829-1

M3 - Article

VL - 47

SP - 8293

EP - 8300

JO - Molecular Biology Reports

JF - Molecular Biology Reports

SN - 1573-4978

IS - 10

ER -